Featured Resources

Introducing: LifeScienceXchange

Patients are counting on your R&D community for the next wave of life-saving medicines.

LifeScienceXchange is the catalyst: a platform for leaders from diverse life science disciplines to connect, learn and collaborate, so that together we bring new treatments to patients faster, sustainably and at scale.

Providing actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format.

It will help you understand trends, benchmark your work, inform strategy and ultimately get your new treatments to patients, faster.

Precision Medicine on LifeScienceXchange provides the events and channels for R&D to unlock human data for precise, patient-centric solutions.

LSX Logo - Better Patient Slogan

Learn faster and put new ideas to work

Market Insights unlock key learnings and actionable ideas from our industry-leading live events. We’ve cut and curated more than 6,000 hours of live recordings into quick-watch cuts, so you can get straight to the moments that matter.

Innovate sooner and benchmark success

Our Technology Showcases give you first sight of the breakthroughs driving our industry. We put you in touch with new developments and vendor success stories, so you can understand the tech, connect with the innovators and benchmark your work against the best

Learn and share ideas with industry leaders

Our Thought Leadership opportunities put you at the heart of the conversations accelerating life sciences R&D today. Hear interviews and presentations with key opinion leaders each month — and join the conversation by putting your questions to them live.

Get the full picture faster

Our Weekly News digest clarifies and condenses the key developments and talking points in life sciences R&D. Each week we identify and summarise the five top stories in quick-read format, so you have a full, clear and balanced picture.

Biomarker Discovery & Development

Breath Biopsy Omni For Comprehensive & Reliable Detection Of VOC Biomarkers In Breath

On-Demand Webinar featuring Dr Elizabeth Crone, Business Development Manager at Owlstone & Dr Hsuan (Tina) Chou, Biomarker Scientist at Owlstone
Genome Editing

Genome Editing Technologies: Pioneering Approaches in Healthcare

Current and upcoming gene editing technologies, such as prime editing and cell line models, have huge potential in applications such as cancer treatment. With the field constantly witnessing new breakthroughs and advances, genome modification holds a lot of promise for the future.
Clinical Development

Toxicity Markers of Cognitive Deterioration in Young Cancer Sufferers

Cancer-related cognitive impairment in young adults found pre-treatment, study reports.
Biomarker Discovery & Development

Are Neuroimmune Proteins the Key to Neurodegenerative Disease Diagnosis?

Unique neuroinflammatory signatures and pathways present in tauopathies could provide greater insight into distinct mechanisms of disease.
Clinical Development

Implementing Patient-Centricity into Biomarker Clinical Trials

How can we better define patient-centric clinical trials within the drug development process?
Clinical Diagnostics

Spatial Analysis of TME Microglia in Melanoma Brain Metastasis

The therapeutic targeting of TME microglia activity may improve the efficacy of treatments for melanoma brain metastasis. Future research could represent a new opportunity in confronting one of the most difficult cancers to treat.
Spatial Analysis

The Spatial Biology Week 2022. Watch now on-demand

Your front-row seat to world innovators
Clinical Development

Cervical Indicators of HIV Risk Found

Study finds predictive link between genital herpes and HIV.
Diagnostic Development

Predicting Preeclampsia Risk with Placental Proteins

A new study by Cedars-Sinai could identify protein biomarkers for preeclampsia.
Clinical Development

Novel Microbial Immunotherapies for Bladder Cancer Treatment

The potential oncolytic applications of Salmonella ZH9 include its use in mitigating diseases such as bladder cancer, with a demonstrated therapeutic effect in cancer models.
Clinical Development

Patient Engagement in Biomarker Development

Christopher Conn, Director of Diagnostics Strategy at Amgen, leads a Discussion Group on patient testing and engagement in biomarker clinical trials.
Biomarker Discovery & Development

Biomarker Testing Consolidation and Implementation Using Multiplex Immunofluorescence

Multiplex immunofluorescence is gaining prevalence in oncology diagnostics; what makes it so effective, and how is it being brought into the clinic?

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery